These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38658424)

  • 1. Enhancement of doxorubicin production in Streptomyces peucetius by genetic engineering and process optimization.
    Yang S; Gui J; Zhang Z; Tang J; Chen S
    AMB Express; 2024 Apr; 14(1):41. PubMed ID: 38658424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced doxorubicin production by Streptomyces peucetius using a combination of classical strain mutation and medium optimization.
    Wang X; Tian X; Wu Y; Shen X; Yang S; Chen S
    Prep Biochem Biotechnol; 2018; 48(6):514-521. PubMed ID: 29939834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene.
    Lomovskaya N; Otten SL; Doi-Katayama Y; Fonstein L; Liu XC; Takatsu T; Inventi-Solari A; Filippini S; Torti F; Colombo AL; Hutchinson CR
    J Bacteriol; 1999 Jan; 181(1):305-18. PubMed ID: 9864344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Streptomyces peucetius drrC gene encodes a UvrA-like protein involved in daunorubicin resistance and production.
    Lomovskaya N; Hong SK; Kim SU; Fonstein L; Furuya K; Hutchinson RC
    J Bacteriol; 1996 Jun; 178(11):3238-45. PubMed ID: 8655504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-resistance mechanism in Streptomyces peucetius: overexpression of drrA, drrB and drrC for doxorubicin enhancement.
    Malla S; Niraula NP; Liou K; Sohng JK
    Microbiol Res; 2010 May; 165(4):259-67. PubMed ID: 19651502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius.
    Madduri K; Kennedy J; Rivola G; Inventi-Solari A; Filippini S; Zanuso G; Colombo AL; Gewain KM; Occi JL; MacNeil DJ; Hutchinson CR
    Nat Biotechnol; 1998 Jan; 16(1):69-74. PubMed ID: 9447597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new peucemycin derivative and impacts of peuR and bldA on peucemycin biosynthesis in Streptomyces peucetius.
    Magar RT; Pham VTT; Poudel PB; Bridget AF; Sohng JK
    Appl Microbiol Biotechnol; 2024 Dec; 108(1):107. PubMed ID: 38217253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and genetic manipulation of the antibiotic down-regulatory gene, wblA ortholog for doxorubicin-producing Streptomyces strain improvement.
    Noh JH; Kim SH; Lee HN; Lee SY; Kim ES
    Appl Microbiol Biotechnol; 2010 Apr; 86(4):1145-53. PubMed ID: 20020285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of ascomycin production via a combination of atmospheric and room temperature plasma mutagenesis in Streptomyces hygroscopicus and medium optimization.
    Yu Z; Shen X; Wu Y; Yang S; Ju D; Chen S
    AMB Express; 2019 Feb; 9(1):25. PubMed ID: 30778695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of tacrolimus production in Streptomyces tsukubaensis by mutagenesis and optimization of fermentation medium using Plackett-Burman design combined with response surface methodology.
    Yan L; Zhang Z; Zhang Y; Yang H; Qiu G; Wang D; Lian Y
    Biotechnol Lett; 2021 Sep; 43(9):1765-1778. PubMed ID: 34021830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production.
    Niraula NP; Kim SH; Sohng JK; Kim ES
    Appl Microbiol Biotechnol; 2010 Jul; 87(4):1187-94. PubMed ID: 20508927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations in doxorubicin production from Streptomyces peucetius.
    Malla S; Niraula NP; Singh B; Liou K; Sohng JK
    Microbiol Res; 2010 Jul; 165(5):427-35. PubMed ID: 20116225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin, 14-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesius. Reprinted from Biotechnology and Bioengineering, Vol. XI, Issue 6, Pages 1101-1110 (1969).
    Arcamone F; Cassinelli G; Fantini G; Grein A; Orezzi P; Pol C; Spalla C
    Biotechnol Bioeng; 2000 Mar; 67(6):704-13. PubMed ID: 10699851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium optimization for ε-poly-L-lysine production by Streptomyces diastatochromogenes using response surface methodology.
    Guo F; Zheng H; Cheng Y; Song S; Zheng Z; Jia S
    Lett Appl Microbiol; 2018 Feb; 66(2):124-131. PubMed ID: 29078007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of doxorubicin-daunorubicin resistance genes in different anthracycline-producing mutants of Streptomyces peucetius.
    Colombo AL; Solinas MM; Perini G; Biamonti G; Zanella G; Caruso M; Torti F; Filippini S; Inventi-Solari A; Garofano L
    J Bacteriol; 1992 Mar; 174(5):1641-6. PubMed ID: 1537806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiently activated ε-poly-L-lysine production by multiple antibiotic-resistance mutations and acidic pH shock optimization in Streptomyces albulus.
    Wang L; Li S; Zhao J; Liu Y; Chen X; Tang L; Mao Z
    Microbiologyopen; 2019 May; 8(5):e00728. PubMed ID: 30298553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic approach to enhance doxorubicin production in panK-integrated Streptomyces peucetius ATCC 27952.
    Song E; Malla S; Yang YH; Lee K; Kim EJ; Lee HC; Sohng JK; Oh MK; Kim BG
    J Ind Microbiol Biotechnol; 2011 Sep; 38(9):1245-53. PubMed ID: 21308395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic engineering of
    Hulst MB; Zhang L; van der Heul HU; Du C; Elsayed SS; Koroleva A; Grocholski T; Wander DPA; Metsä-Ketelä M; Neefjes JJC; van Wezel GP
    Front Bioeng Biotechnol; 2024; 12():1363803. PubMed ID: 38481571
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimization of fermentation conditions and medium components for chrysomycin a production by Streptomyces sp. 891-B6.
    Hu Z; Weng Q; Cai Z; Zhang H
    BMC Microbiol; 2024 Apr; 24(1):120. PubMed ID: 38582825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of fermentation conditions for surfactin production by B. subtilis YPS-32.
    Zhou Y; Yang X; Li Q; Peng Z; Li J; Zhang J
    BMC Microbiol; 2023 Apr; 23(1):117. PubMed ID: 37101148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.